Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Clinical Rheumatology
|
June 7, 2022
Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA
Theresa Hunter, Michael Grabner, Julie Birt, et al.
Rheumatology (Oxford, England)
|
February 11, 2024
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis
Dennis McGonagle, Arthur Kavanaugh, Iain B McInnes, et al.
Arthritis Care & Research
|
June 25, 2019
Efficacy and Safety of Long-Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis: Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus Methotrexate
Roy Fleischmann, Tsutomu Takeuchi, Michael Schiff, et al.
Rheumatology and Therapy
|
April 18, 2024
Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial
Kurt de Vlam, Walter P Maksymowych, Gaia Gallo, et al.
Current Medical Research and Opinion
|
July 14, 2007
A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis
Joseph Huffstutter, W David Craig, Gregory Schimizzi, et al.
The Journal of Rheumatology
|
May 3, 2020
Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience From the Corrona PsA/SpA Registry
Philip J Mease, Carol J Etzel, William J Huster, et al.
Rheumatology and Therapy
|
December 19, 2025
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials
John D Reveille, Martin Rudwaleit, Proton Rahman, et al.
Arthritis and Rheumatism
|
June 10, 2004
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists
Laurie Bergstrom, David E Yocum, Neil M Ampel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 26, 2016
Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
John N Galgiani, Neil M Ampel, Janis E Blair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2016
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
John N Galgiani, Neil M Ampel, Janis E Blair, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Clinical Rheumatology
|
June 7, 2022
Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA
Theresa Hunter, Michael Grabner, Julie Birt, et al.
Rheumatology (Oxford, England)
|
February 11, 2024
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis
Dennis McGonagle, Arthur Kavanaugh, Iain B McInnes, et al.
Arthritis Care & Research
|
June 25, 2019
Efficacy and Safety of Long-Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis: Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus Methotrexate
Roy Fleischmann, Tsutomu Takeuchi, Michael Schiff, et al.
Rheumatology and Therapy
|
April 18, 2024
Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial
Kurt de Vlam, Walter P Maksymowych, Gaia Gallo, et al.
Current Medical Research and Opinion
|
July 14, 2007
A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis
Joseph Huffstutter, W David Craig, Gregory Schimizzi, et al.
The Journal of Rheumatology
|
May 3, 2020
Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience From the Corrona PsA/SpA Registry
Philip J Mease, Carol J Etzel, William J Huster, et al.
Rheumatology and Therapy
|
December 19, 2025
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials
John D Reveille, Martin Rudwaleit, Proton Rahman, et al.
Arthritis and Rheumatism
|
June 10, 2004
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists
Laurie Bergstrom, David E Yocum, Neil M Ampel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 26, 2016
Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
John N Galgiani, Neil M Ampel, Janis E Blair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 30, 2016
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
John N Galgiani, Neil M Ampel, Janis E Blair, et al.
Page
of 3